Skip to main content
. 2020 Oct 9;21(20):7451. doi: 10.3390/ijms21207451

Figure 6.

Figure 6

Human vitreous levels of eicosanoids in PDR subtypes treated with bevacizumab, VH (n = 11) vs. TRD (n = 8) eyes. Comparison of levels (pg/mL) of individual EET and DiHETE as well as total levels in VH vs. TRD.